Healthcare IT Today August 11, 2020
If you want an example of how the pandemic is fostering the growth of long-distance medicine, look no further than the following.
Maimonides Medical Center and Meridian Health System have agreed to work with remote diagnostic tech vendor Nanowear to conduct a clinical trial. The goal of the project is to monitor confirmed or suspected COVID-19 patients remotely to detect signs of clinical deterioration.
Nanowear will support the project by providing cloth-based nanosensors. Users wear a one-size-fits-all adjustable undergarment designed to detect physiological and biomarker changes. The Nanowear platform, SimpleSENSE, captures real-time ECG data, systolic and diastolic blood pressure, blood flow hemodynamics, respiration, long volume and fluid, and temperature trends.
As the vendor’s news release states, gathering such data remotely...